J Mullen

Summary

Affiliation: AstraZeneca R and D

Publications

  1. ncbi A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study
    J Mullen
    AstraZeneca Pharmaceuticals LP, Wilmington, Delaware 19850, USA
    Clin Ther 23:1839-54. 2001

Detail Information

Publications1

  1. ncbi A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study
    J Mullen
    AstraZeneca Pharmaceuticals LP, Wilmington, Delaware 19850, USA
    Clin Ther 23:1839-54. 2001
    ..The few published direct comparative studies of the tolerability and efficacy of atypical antipsychotic agents were performed in relatively homogeneous populations that may not be typical of patients seen in clinical practice...